Combination of radiation therapy-immunotherapy for head and neck cancers: Promises kept?

被引：2
|
作者：
Huguet, F. [1 ]
Durand, B. [1 ]
Atallah, S. [2 ]
Prebet, C. [3 ]
Richard, S. [3 ]
Baujat, B. [2 ]
机构：
[1] Hop Tenon, Serv Oncol Radiotherapie, 4 Rue Chine, F-75020 Paris, France
[2] Serv Oto Rhino Laryngol Chirurg Cerv Faciale, Paris, France
[3] Sorbonne Univ, Serv Oncol Med, Hop Tenon, AP HP, Paris, France
来源：
CANCER RADIOTHERAPIE | 2021年 / 25卷 / 08期
关键词：
Head and neck cancer; Squamous cell carcinoma; Radiotherapy; Chemoradiotherapy; Cisplatin; Immunotherapy; Immune checkpoint inhibitors; PDL1; PD1; Abscopal effect; SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; CHEMOTHERAPY; NIVOLUMAB; CETUXIMAB; CHEMORADIOTHERAPY; RECURRENT; IMMUNITY; SAFETY; PHASE;
D O I：
10.1016/j.canrad.2021.08.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemoradiotherapy with concurrent cisplatin has been the standard treatment for locally advanced headand neck squamous cell carcinoma (HNSCC) for over 20 years. Recently, immunotherapy, a new therapeutic class, has emerged for patients with recurrent or metastatic HNSCC and has significantly extendedtheir survival. Will it bring the same benefit to patients with localized tumors? There is a strong rationale for combining radiation therapy and checkpoint inhibitors for HNSCC. Indeed, radiation therapy canhave both immunostimulatory and immunomodulatory effects. This is what explains the famous abscopal effect. The aim of this review is to present the data available on the combination of radiation therapyand immunotherapy for HNSCC. (c) 2021 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. Allrights reserved.
引用
收藏
页码：811 / 815
页数：5
相关论文
共 50 条
  • [1] Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
    Espinosa, Maria L.
    Abad, Chelsea
    Kurtzman, Yaira
    Abdulla, Farah R.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Chemo-immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
    Belgioia, L.
    Becherini, C.
    Bacigalupo, A.
    Bonomo, P.
    ORAL ONCOLOGY, 2022, 127
  • [3] Immunotherapy in head and neck cancers
    Reverdy, Thibaut
    Gau, Max
    Karabajakian, Andy
    Neidhardt, Eve-Marie
    Fayette, Jerome
    BULLETIN DU CANCER, 2018, 105 : S35 - S42
  • [4] New developments in radiation oncology for head and neck cancers
    Resl, Christoph
    Georg, Petra
    Doeller, Carmen
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, : 170 - 175
  • [5] An update on radiation therapy in head and neck cancers
    Mazzola, Rosario
    Fiorentino, Alba
    Ricchetti, Francesco
    Gregucci, Fabiana
    Corradini, Stefanie
    Alongi, Filippo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (04) : 359 - 364
  • [6] Combination antiangiogenic therapy and radiation in head and neck cancers
    Hsu, Heng-Wei
    Wall, Nathan R.
    Hsueh, Chung-Tsen
    Kim, Seungwon
    Ferris, Robert L.
    Chen, Chien-Shing
    Mirshahidi, Saied
    ORAL ONCOLOGY, 2014, 50 (01) : 19 - 26
  • [7] A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
    Chin, Re-, I
    Schiff, Joshua P.
    Brenneman, Randall J.
    Gay, Hiram A.
    Thorstad, Wade L.
    Lin, Alexander J.
    CANCERS, 2021, 13 (21)
  • [8] Nanoparticle therapy for head and neck cancers
    Hoffmann, Caroline
    Shen, Colette
    Le Tourneau, Christophe
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (03) : 177 - 184
  • [9] Combining Systemic Therapy With Radiation: Head and Neck Cancer Treatments in an Era of Targeted Agents and Immunotherapy
    Vasudevan, Harish N.
    Yom, Sue S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 907 - 913
  • [10] Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review
    Mitrea, Diana A.
    Froicu, Eliza M.
    Prenen, Hans
    Gambacorta, Maria A.
    Span, Paul N.
    Poortmans, Philip
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 199
12345